Bal Pharma Fund Raise

Other Announcement

Bal Pharma Other Announcement

Bal Pharma filed a Reg 32 statement confirming no deviation in its ₹2.10 Cr preferential warrant proceeds, with nothing utilised by September 30, 2026. The amount remains fully unutilised.

Value

₹2.10 Cr

Financial Results

Bal Pharma Q2 FY27 Results: Net Profit ₹1.4 Cr, Up 100.0% YoY

Bal Pharma Ltd reported revenue from operations of ₹89.9 Cr (+21.5% YoY) and net profit of ₹1.4 Cr (+100.0% YoY) for Q2 FY27.

Key figure

Net profit ₹1.4 Cr · +100.0% YoY

Board Meeting Date

Bal Pharma Board Meeting Date

Bal Pharma Limited informs exchanges of a board meeting on November 11, 2026, to consider unaudited standalone and consolidated results for Q2 FY2026-27. This is a prior intimation with no results figures attached yet.

Other Announcement

Bal Pharma Other Announcement

Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.

Dividend

Bal Pharma Dividend

Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.

Management Change

Bal Pharma Management Change

Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.

Fund RaiseOm Metallogic Ltd 544559

Om Metallogic Fund Raise

Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.

Fund RaiseVirinchi Ltd VIRINCHIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Virinchi Fund Raise of ₹30 Cr

Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.

Value

₹30.00 Cr

Execution

Warrant tenure not exceeding 18 months from allotment

Fund RaiseIIFL Finance Ltd IIFLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

IIFL Finance Fund Raise of ₹6,414 Cr

IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.

Value

₹6,414 Cr

Fund RaiseBajaj Finance Ltd BAJFINANCEAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bajaj Finance Fund Raise of ₹5,800 Cr

Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.

Value

₹5,800 Cr

Fund RaiseCholamandalam Investment & Finance Company Ltd CHOLAFINAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr

Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.

Value

₹5,000 Cr

Execution

Allotment to be completed within 365 days of shareholder approval

Fund RaiseHB Leasing & Finance Co Ltd HBLEAS

HB Leasing & Finance Co Fund Raise

HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.